Meddenovo
Lyon, FR · Founded 2023 · 10 employees on LinkedIn · 1 known investors
Meddenovo develops Mexa, an AI-powered platform for de novo design of cyclic peptide drug candidates. The company serves pharmaceutical partners seeking to discover novel peptide therapeutics for oncology, radiopharmaceuticals, and metabolic diseases.
Founders & leadership
Meddenovo was founded in 2023 by Ilke Ugur Marion.
IU
Ilke Ugur MarioninFounder
Investors · 1
Frequently asked questions
- What does Meddenovo do?
- Meddenovo develops Mexa, an AI-powered platform for de novo design of cyclic peptide drug candidates. The company serves pharmaceutical partners seeking to discover novel peptide therapeutics for oncology, radiopharmaceuticals, and metabolic diseases.
- Who founded Meddenovo?
- Meddenovo was founded by Ilke Ugur Marion in 2023.
- Who are Meddenovo's investors?
- Meddenovo's investors include ACT Venture Partners.
- Where is Meddenovo headquartered?
- Meddenovo is headquartered in Lyon, FR.